PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Inovio Pharmaceuticals, Inc. (INO)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US45773H2013

CUSIP

45773H201

Sector

Healthcare

IPO Date

Feb 12, 1998

Highlights

Market Cap

$70.76M

EPS (TTM)

-$4.43

Total Revenue (TTM)

$203.41K

Gross Profit (TTM)

-$1.56M

EBITDA (TTM)

-$109.89M

Year Range

$1.91 - $14.75

Target Price

$10.67

Short %

13.59%

Short Ratio

11.22

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
INO vs. MDU
Popular comparisons:
INO vs. MDU

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Inovio Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%400.00%JulyAugustSeptemberOctoberNovemberDecember
-99.74%
402.03%
INO (Inovio Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Returns By Period

Inovio Pharmaceuticals, Inc. had a return of -69.93% year-to-date (YTD) and -62.60% in the last 12 months. Over the past 10 years, Inovio Pharmaceuticals, Inc. had an annualized return of -33.64%, while the S&P 500 had an annualized return of 11.06%, indicating that Inovio Pharmaceuticals, Inc. did not perform as well as the benchmark.


INO

YTD

-69.93%

1M

-53.65%

6M

-77.26%

1Y

-62.60%

5Y*

-45.92%

10Y*

-33.64%

^GSPC (Benchmark)

YTD

24.34%

1M

0.23%

6M

8.53%

1Y

24.95%

5Y*

13.01%

10Y*

11.06%

Monthly Returns

The table below presents the monthly returns of INO, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-11.93%64.38%56.66%-17.51%-11.53%-20.24%31.93%-32.27%-19.94%-8.65%-18.18%-69.93%
20236.41%-24.10%-34.92%-5.79%-22.51%-25.41%19.15%-15.43%-13.54%-6.35%8.21%29.38%-67.31%
2022-17.03%-21.74%10.80%-23.96%-31.50%-7.49%14.45%15.66%-24.67%25.22%-5.56%-23.53%-68.74%
202144.07%-12.94%-16.40%-26.62%10.87%22.78%-9.39%2.86%-17.13%-0.28%1.40%-31.08%-43.62%
202037.27%-5.52%73.83%61.69%22.61%82.71%-27.87%-38.32%-3.25%-15.09%24.06%-27.58%168.18%
201925.25%-26.95%1.91%0.80%-36.44%23.01%-6.12%-21.74%-5.09%3.90%18.31%30.95%-17.50%
201810.41%-10.09%14.88%-6.79%8.43%-17.65%2.30%31.17%5.70%-11.33%8.52%-25.23%-3.15%
2017-4.90%6.82%-6.10%-4.98%20.03%3.84%-29.08%6.94%6.83%-8.04%-21.27%-10.02%-40.38%
2016-0.60%-5.69%38.25%20.32%8.02%-18.37%6.93%-7.19%1.64%-30.58%9.43%-1.98%3.27%
2015-9.15%-15.17%15.34%0.00%3.06%-2.97%-10.66%2.74%-22.83%9.52%17.06%-9.31%-26.80%
2014-11.03%27.52%1.22%-28.83%-5.06%20.11%-6.57%4.85%-6.99%15.33%-14.79%-5.17%-20.86%
201331.13%5.34%-13.77%2.50%11.82%16.73%119.82%-2.86%21.76%-16.43%21.39%38.10%480.58%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of INO is 16, meaning it’s performing worse than 84% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of INO is 1616
Overall Rank
The Sharpe Ratio Rank of INO is 1717
Sharpe Ratio Rank
The Sortino Ratio Rank of INO is 1919
Sortino Ratio Rank
The Omega Ratio Rank of INO is 1919
Omega Ratio Rank
The Calmar Ratio Rank of INO is 1414
Calmar Ratio Rank
The Martin Ratio Rank of INO is 1010
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Inovio Pharmaceuticals, Inc. (INO) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for INO, currently valued at -0.63, compared to the broader market-4.00-2.000.002.00-0.632.10
The chart of Sortino ratio for INO, currently valued at -0.69, compared to the broader market-4.00-2.000.002.004.00-0.692.80
The chart of Omega ratio for INO, currently valued at 0.91, compared to the broader market0.501.001.502.000.911.39
The chart of Calmar ratio for INO, currently valued at -0.60, compared to the broader market0.002.004.006.00-0.603.09
The chart of Martin ratio for INO, currently valued at -1.42, compared to the broader market-5.000.005.0010.0015.0020.0025.00-1.4213.49
INO
^GSPC

The current Inovio Pharmaceuticals, Inc. Sharpe ratio is -0.63. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Inovio Pharmaceuticals, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.63
2.10
INO (Inovio Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

Inovio Pharmaceuticals, Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%0.05%0.10%0.15%0.20%0.25%$0.00$0.02$0.04$0.06$0.08$0.10$0.12$0.142017201820192020202120222023
Dividends
Dividend Yield
PeriodTTM2023202220212020201920182017
Dividend$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.14

Dividend yield

0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.28%

Monthly Dividends

The table displays the monthly dividend distributions for Inovio Pharmaceuticals, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2017$0.07$0.07$0.00$0.00$0.00$0.14

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-99.92%
-2.62%
INO (Inovio Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Inovio Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Inovio Pharmaceuticals, Inc. was 99.92%, occurring on Dec 18, 2024. The portfolio has not yet recovered.

The current Inovio Pharmaceuticals, Inc. drawdown is 99.92%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.92%Mar 6, 20006234Dec 18, 2024
-43.08%Jan 12, 1999144Aug 9, 1999108Jan 11, 2000252
-38.65%Feb 18, 20004Feb 24, 20006Mar 3, 200010
-22.73%Jan 12, 20005Jan 19, 200011Feb 3, 200016
-11.86%Dec 15, 19985Dec 21, 199811Jan 7, 199916

Volatility

Volatility Chart

The current Inovio Pharmaceuticals, Inc. volatility is 50.56%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%JulyAugustSeptemberOctoberNovemberDecember
50.56%
3.79%
INO (Inovio Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Inovio Pharmaceuticals, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Inovio Pharmaceuticals, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab